AU Stock MarketDetailed Quotes
BDX BCAL Diagnostics Ltd
- 0.091
- -0.004-4.21%
20min DelayMarket Closed Dec 27 16:00 AET
33.30MMarket Cap-3.50P/E (Static)
0.099High0.091Low155.27KVolume0.095Open0.095Pre Close14.87KTurnover0.18552wk High0.08%Turnover Ratio365.97MShares0.08552wk Low-0.026EPS TTM17.76MFloat Cap0.275Historical HighLossP/E (Static)195.13MShs Float0.051Historical Low-0.026EPS LYR8.42%Amplitude--Dividend TTM3.79P/B1Lot Size--Div YieldTTM
About BCAL Diagnostics Ltd Company
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Company Profile
SymbolBDX
Company NameBCAL Diagnostics Ltd
Founded2010
MarketASX
Fiscal Year Ends06-30
AddressQueen Victoria Building GPO Box Q128
CitySydney
CountryAustralia
Zip Code1230
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Jayne Andrea Shaw
- Executive Chairman,Executive Director
- --
- Ronald (Ron) Anthony Phillips
- Non-Executive Director
- --
- Mark Douglas Irving Burrows
- Non-Executive Director
- --
- Jonathan Alfred Grey Trollip
- Non-Executive Director
- --
- John Hurrell
- Non-Executive Director
- --
- David George Darling
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data